Knockdown of SphK2 expression by siRNA curtailed proliferative capability of colon cancer LoVo cells and inhibited their migratory and invasion potential suggesting that SphK2 confers malignant phenotype of colon cancer cells. This evidence concerns the gene SPHK2 and colonic neoplasm.